Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prostate Cancer IRE Study (PRIS) - A Randomized Controlled Trial Comparing Focal to Radical Treatment in Localized Prostate Cancer

NCT05513443 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT05513443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05513443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prostate Cancer IRE Study (PRIS) - A Randomized Controlled Trial Comparing Focal to Radical Treatment in Localized Prostate Cancer
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 1, 2022
Completion date
June 1, 2027
Enrollment
184 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer